These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 25249327
21. Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial. Sedhain A, Hada R, Agrawal RK, Bhattarai GR, Baral A. BMC Nephrol; 2018 Jul 11; 19(1):175. PubMed ID: 29996800 [Abstract] [Full Text] [Related]
22. Optimal exposure of mycophenolic acid for induction therapy of childhood lupus nephritis patients: an observational cohort study. Zhang L, Chen L, Liu X, Huang Z, Zheng Y, Tang K, Jiang X, Chen P. Rheumatology (Oxford); 2024 Sep 01; 63(SI2):SI180-SI187. PubMed ID: 38730553 [Abstract] [Full Text] [Related]
30. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus. Dittrich K, Ross S, Benz K, Amann K, Dötsch J. Klin Padiatr; 2009 Dec 01; 221(7):425-9. PubMed ID: 20013565 [Abstract] [Full Text] [Related]
33. Therapeutic Drug Monitoring of Mycophenolic Acid in Lupus Nephritis: A Review of Current Literature. Łuszczyńska P, Pawiński T. Ther Drug Monit; 2015 Dec 01; 37(6):711-7. PubMed ID: 26034895 [Abstract] [Full Text] [Related]
34. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials. Zhu B, Chen N, Lin Y, Ren H, Zhang W, Wang W, Pan X, Yu H. Nephrol Dial Transplant; 2007 Jul 01; 22(7):1933-42. PubMed ID: 17405792 [Abstract] [Full Text] [Related]
35. Mycophenolate mofetil for remission induction in severe lupus nephritis. Cross J, Dwomoa A, Andrews P, Burns A, Gordon C, Main J, Mathieson P, O'Donoghue D, Jayne D, Renal Association Clinical Trials Subcommittee. Nephron Clin Pract; 2005 Jul 01; 100(3):c92-100. PubMed ID: 15824513 [Abstract] [Full Text] [Related]
36. Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis. Jesus D, Rodrigues M, da Silva JAP, Inês L. Lupus; 2018 Jul 01; 27(8):1358-1362. PubMed ID: 29448882 [Abstract] [Full Text] [Related]
39. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study. Moroni G, Raffiotta F, Trezzi B, Giglio E, Mezzina N, Del Papa N, Meroni P, Messa P, Sinico AR. Rheumatology (Oxford); 2014 Sep 01; 53(9):1570-7. PubMed ID: 24505125 [Abstract] [Full Text] [Related]
40. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, Boletis J, Frangou E, Houssiau FA, Hollis J, Karras A, Marchiori F, Marks SD, Moroni G, Mosca M, Parodis I, Praga M, Schneider M, Smolen JS, Tesar V, Trachana M, van Vollenhoven RF, Voskuyl AE, Teng YKO, van Leew B, Bertsias G, Jayne D, Boumpas DT. Ann Rheum Dis; 2020 Jun 01; 79(6):713-723. PubMed ID: 32220834 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]